Choroidal beat strength over mean blur rate (BOM) increased significantly from 0.94 to 1.11 after 6 months of androgen deprivation therapy despite stable blood flow and arterial stiffness.
Does androgen deprivation therapy alter choroidal microvascular dynamics and large-artery stiffness in men with prostate cancer?
Androgen deprivation therapy increases choroidal microvascular resistance within 6 months, preceding changes in large-artery stiffness, suggesting a 'microcirculation-first' model of vascular dysfunction.
Absolute Event Rate: 0% vs 0%
ABSTRACT Objective To determine whether androgen deprivation therapy (ADT) alters laser speckle flowgraphy (LSFG)‐detectable choroidal microvascular dynamics: mean blur rate (MBR, blood flow) and beat strength over MBR (BOM, microvascular resistance). We also investigated whether such changes emerge even when cardio‐ankle vascular index (CAVI)‐assessed large‐artery stiffness remains unchanged. Methods This study included 17 right eyes of 17 men with prostate cancer. Serum testosterone, CAVI, and choroidal parameters (MBR, BOM) were obtained at baseline and 6 months post‐ADT. Central choroidal thickness (CCT) and ocular perfusion pressure (OPP) were also recorded. Results Serum testosterone significantly decreased (4.45 ± 1.96 to 0.20 ± 0.08 ng/mL; p < 0.001) after 6 months. Choroidal BOM increased significantly (0.94 ± 0.31 to 1.11 ± 0.31; p = 0.028), whereas CAVI (10.70 ± 1.28 to 10.68 ± 1.19), choroidal MBR (8.46 ± 4.50 to 7.89 ± 3.48), CCT, and OPP did not change significantly. Conclusion Choroidal BOM increased significantly during the initial 6 months of ADT, indicating higher microvascular resistance despite stable choroidal blood flow and unchanged large artery stiffness. This supports a “microcirculation‐first” model. LSFG‐derived BOM may serve as a biomarker for early detection and monitoring of microcirculatory dysfunction under systemic testosterone suppression.
Hashimoto et al. (Tue,) reported a other. Choroidal beat strength over mean blur rate (BOM) increased significantly from 0.94 to 1.11 after 6 months of androgen deprivation therapy despite stable blood flow and arterial stiffness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: